259 filings
Page 7 of 13
8-K
nrh6o
19 Mar 19
Other Events
9:08pm
8-K
b1fzyw1i
27 Feb 19
Sage Therapeutics Announces Closing of $575 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares
4:05pm
8-K
ldfdno6cmmhm54r95j
27 Feb 19
Sage Therapeutics Announces Proposed Public Offering of Common Stock
8:08am
424B5
okjuk6
27 Feb 19
Prospectus supplement for primary offering
8:04am
424B5
xmfbgblhs0nz7l 37an4
25 Feb 19
Prospectus supplement for primary offering
4:07pm
S-8
6jd4exm
19 Feb 19
Registration of securities for employees
7:50am
8-K
sh7rk8j21j
19 Feb 19
Sage Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress
7:07am
8-K
x2lwh7wpjk34hsnj aho
23 Jan 19
Sage Therapeutics Appoints Elizabeth Barrett and George Golumbeski to Board of Directors
5:03pm
8-K
3um5nc52paqf8o7
7 Jan 19
Regulation FD Disclosure
7:30am
S-3ASR
mzl2yh61d6a9j87 2g
18 Dec 18
Automatic shelf registration
4:33pm
CT ORDER
hi8608f2w27ltvscqapq
3 Dec 18
Confidential treatment order
12:13pm
8-K
8ruayxwxhmimen3guau
20 Nov 18
Sage Therapeutics Receives Notification of PDUFA Extension
4:06pm
S-8
w3d cffgfmjm
7 Nov 18
Registration of securities for employees
4:18pm
8-K
v3b gz4sqxo7
6 Nov 18
Sage Therapeutics Announces Third Quarter 2018 Financial Results and Highlights Pipeline and Business Progress
6:46am
8-K
w825e34e3h3t44jkqh
2 Nov 18
Other Events
5:26pm
8-K
wwscq3gk6mm2871eip0
7 Aug 18
Results of Operations and Financial Condition
7:30am
8-K
t6rxj3jh2j9 4m
14 Jun 18
Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic Collaboration
12:00am